Banco Macro S.A. (BMA) Stock Price & How to Invest

Banco Macro (NYSE: BMA) is one of the largest privately owned banks in Argentina, with a national branch footprint and a strong presence outside Buenos Aires in the country's interior provinces. Each ADR represents ten Class B common shares. The bank offers retail and commercial banking, lending to individuals and small and medium businesses, deposits, payments, and, increasingly, digital finance (it took a 50% stake in the Personal Pay wallet to tap Telecom's customer base). It has historically run high capital ratios and holds roughly a mid-teens share of the Argentine banking system.

The investment picture is really a macro picture. Banco Macro's revenue, margins, and loan growth swing with Argentine inflation, interest rates, and the peso, all of which have been extraordinarily volatile. The 2025 and 2026 story centers on whether Argentina's disinflation and stabilization efforts hold, which would normally revive net interest margin, return on equity, and credit demand. Reported earnings have been choppy (a strong Q2 2025 offset by a weaker Q4 2025 hit by restructuring charges), and after a large share rally some observers view the ADR as richly valued versus historical norms. It is a high-beta, single-country financial rather than a stable dividend compounder.

Argentina carries some of the highest macro risk of any major economy, and BMA concentrates that risk in a single stock. The peso can devalue sharply, which erodes US-dollar-denominated ADR value even when peso earnings look fine. Inflation, capital controls, government policy shifts, and sovereign stress all feed directly into the bank's results and its accounting (which uses inflation adjustment). Earnings have been volatile quarter to quarter, and after a large rally the ADR has at times traded well above some analysts' fair-value estimates, so valuation and political risk can both bite.

9 analysts publish price targets on BMA, averaging $115.47 against a $91.90 price as of August 2026, or +25.6%. The published targets run from $79.88 to $142.56, a moderate spread, and the ratings split 9 buy, 0 hold, 0 sell. Over the last six months there has been 1 raise and 1 cut among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full BMA forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Banco Macro S.A.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Argentina disinflation and rate normalization. The core driver is Argentina's path from very high inflation toward a more stable regime. The most optimistic published target, $142.56, assumes this works close to its best case.

The case against. Argentina carries some of the highest macro risk of any major economy, and BMA concentrates that risk in a single stock. The most pessimistic target, $79.88, is roughly what BMA is worth if this bites instead.

Read the full bull and bear case on BMA, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Banco Macro S.A.'s investor relations page or your broker.

• Recent ADR price: ~$100 range in early 2026
• Q2 2025 net income: ~ARS 149.5B
• 9M 2025 net income: ~ARS 176.7B (down ~35% YoY)
• Q4 2025 net income: ~ARS 100B (down ~26% YoY)
• Return on equity: ~10% (well below its ~24% 10-year median)
• Argentine market share: ~15% of the banking sector

Argentine bank financials are reported in inflation-adjusted pesos, which makes reported figures hard to compare across periods and against US peers. ROE has compressed sharply from historical highs as rates and inflation moderated, and Q4 2025 was dented by restructuring charges. After a strong share rally, some valuation screens flagged the ADR as trading well above estimated fair value.

Other names that sit close to BMA: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get BMA exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so BMA sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where BMA fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

BMA offers concentrated exposure to a well-capitalized Argentine bank whose fortunes are tied directly to Argentina's macro, currency, and rate path, which cuts both ways.

Whether BMA is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is BMA a buy or a sell?, and where the stock could go from here in the BMA stock forecast.

For income investors, whether BMA pays a dividend and how the payout looks is covered in does BMA pay a dividend? And to weigh BMA against a peer, read the full side-by-side comparisons: BMA vs GGAL and BMA vs BBVA.